PMID: 9548412Apr 21, 1998Paper

Expression of dipeptidylaminopeptidase IV/CD26 in peripheral blood lymphocytes of hemophilic subjects

European Journal of Haematology
R InvernizziG Gamba

Abstract

CD26 antigen, a 110 kDa membrane glycoprotein with exopeptidase activity (DAP IV), is an activation marker of T lymphocytes preferentially expressed on CD4+ memory cells and involved in T cell proliferation and IL-2 production after antigenic stimulation. We employed cytochemical and immunocytochemical techniques to study DAP IV/CD26 expression in circulating lymphocytes from 40 hemophilic patients, chronically treated with coagulation factors, in order to verify the possible involvement of this molecule in the immunological alterations of hemophilia. In all the hemophiliacs DAP IV activity was significantly lower than in the controls, independently of the quantity of blood transfused and previous exposure to viruses. This reduction may be responsible for the impaired proliferative response of lymphocytes to antigens and mitogens, notoriously observed in hemophilia. Whereas in the group of HIV- patients CD26 expression was similar to that of normal controls, in the 8 HIV+ hemophilic patients both percentages of positive lymphocytes and intensity of staining were significantly lower. In only 4 of the 8 cases was this deficit associated with CD4+ cell depletion. The significant selective loss of CD26 expression observed in HIV+ p...Continue Reading

References

Jul 1, 1976·The Biochemical Journal·A J KennyA R Young
May 1, 1992·Scandinavian Journal of Immunology·A J UlmerH D Flad
Jun 1, 1991·Scandinavian Journal of Immunology·T MatternA J Ulmer
Nov 7, 1985·The New England Journal of Medicine·J KaplanJ Levy
Mar 1, 1986·Clinical Immunology and Immunopathology·J W MannhalterM M Eibl
Jan 13, 1983·The New England Journal of Medicine·M M LedermanB Schacter
Mar 1, 1983·Annals of Internal Medicine·J C GoldsmithG W Hunninghake
Feb 1, 1984·Annals of Internal Medicine·P GascónN S Young
Sep 1, 1984·American Journal of Clinical Pathology·A D CrockardD Catovsky
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T TanakaC Morimoto
Nov 5, 1993·Science·M Balter
Apr 1, 1994·Immunology Today·B Fleischer
Jan 1, 1996·Research in Immunology·M L GougeonA G Hovanessian

❮ Previous
Next ❯

Citations

Mar 31, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Satoshi YamasakiHiromi Iwasaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.